ArticleMolecular cancer therapeutics2013

Sym004, a novel anti-EGFR antibody mixture, augments radiation response in human lung and head and neck cancers.

Shyhmin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.